[{"indications": "Indications\u00a0adults, nausea and vomiting, particularly\r\nin gastro-intestinal disorders (section 1.2) and treatment\r\nwith cytotoxics or radiotherapy; migraine (section 4.7.4.1)Patients under 20 years\u00a0Use restricted to severe\r\nintractable vomiting of known cause, vomiting of radiotherapy and\r\ncytotoxics, aid to gastro-intestinal intubation, premedication; dose\r\nshould be determined on the basis of body-weight", "name": "METOCLOPRAMIDE HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.6 Drugs used in nausea and vertigo", "Domperidone and metoclopramide", "METOCLOPRAMIDE HYDROCHLORIDE"], "cautions": "Cautions\u00a0elderly, young\r\nadults (15\u201319 years old), and children; atopic allergy (including asthma); cardiac conduction disturbances (and concomitant\r\nuse of other drugs affecting cardiac conduction);  may mask underlying disorders such as cerebral irritation; acute porphyria (section 9.8.2); epilepsy; interactions: Appendix 1 (metoclopramide)", "side-effects": "Side-effects\u00a0extrapyramidal effects (especially in children\r\nand young adults (15\u201319 years old)\u2014see above),\r\nhyperprolactinaemia, occasionally tardive dyskinesia on prolonged\r\nadministration; also reported, dyspnoea, anxiety, confusion, drowsiness,\r\ndizziness, tremor, restlessness, diarrhoea, depression, neuroleptic\r\nmalignant syndrome, visual disturbances, rashes, pruritus, oedema;\r\ncardiac conduction abnormalities reported following intravenous administration; rarely methaemoglobinaemia (more severe in G6PD deficiency)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3432.htm", "doses": ["By mouth or by intramuscular injection or by\r\nintravenous injection over 1\u20132 minutes, nausea and vomiting,\r\n10\u00a0mg (5\u00a0mg in young adults 15\u201319 years, body-weight under 60\u00a0kg)\r\n3 times daily; child up to 1 year (body-weight\r\nup to 10\u00a0kg) 100\u00a0micrograms/kg (max. 1\u00a0mg) twice daily, 1\u20133 years\r\n(body-weight 10\u201314\u00a0kg) 1\u00a0mg 2\u20133 times daily, 3\u20135 years (body-weight\r\n15\u201319\u00a0kg) 2\u00a0mg 2\u20133 times daily, 5\u20139 years (body-weight 20\u201329\u00a0kg) 2.5\u00a0mg\r\n3 times daily, 9\u201315 years (body-weight 30\u00a0kg and over) 5\u00a0mg 3 times\r\ndaily", "Daily dose of metoclopramide should not normally\r\nexceed 500\u00a0micrograms/kg, particularly for children and young adults\r\n(restricted use, see above)", "For diagnostic procedures, as a single dose 5\u201310 minutes before\r\nexamination, 10\u201320\u00a0mg (10\u00a0mg in young adults 15\u201319 years); child under 3 years 1\u00a0mg, 3\u20135 years 2\u00a0mg, 5\u20139 years\r\n2.5\u00a0mg, 9\u201314 years 5\u00a0mg"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}, {"indications": "Indications\u00a0adults, nausea and vomiting, particularly\r\nin gastro-intestinal disorders (section 1.2) and treatment\r\nwith cytotoxics or radiotherapy; migraine (section 4.7.4.1)Patients under 20 years\u00a0Use restricted to severe\r\nintractable vomiting of known cause, vomiting of radiotherapy and\r\ncytotoxics, aid to gastro-intestinal intubation, premedication; dose\r\nshould be determined on the basis of body-weight", "name": "METOCLOPRAMIDE HYDROCHLORIDE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.6 Drugs used in nausea and vertigo", "Domperidone and metoclopramide", "METOCLOPRAMIDE HYDROCHLORIDE", "Modified release"], "cautions": "Cautions\u00a0elderly, young\r\nadults (15\u201319 years old), and children; atopic allergy (including asthma); cardiac conduction disturbances (and concomitant\r\nuse of other drugs affecting cardiac conduction);  may mask underlying disorders such as cerebral irritation; acute porphyria (section 9.8.2); epilepsy; interactions: Appendix 1 (metoclopramide)", "side-effects": "Side-effects\u00a0extrapyramidal effects (especially in children\r\nand young adults (15\u201319 years old)\u2014see above),\r\nhyperprolactinaemia, occasionally tardive dyskinesia on prolonged\r\nadministration; also reported, dyspnoea, anxiety, confusion, drowsiness,\r\ndizziness, tremor, restlessness, diarrhoea, depression, neuroleptic\r\nmalignant syndrome, visual disturbances, rashes, pruritus, oedema;\r\ncardiac conduction abnormalities reported following intravenous administration; rarely methaemoglobinaemia (more severe in G6PD deficiency)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3439.htm", "doses": ["By mouth or by intramuscular injection or by\r\nintravenous injection over 1\u20132 minutes, nausea and vomiting,\r\n10\u00a0mg (5\u00a0mg in young adults 15\u201319 years, body-weight under 60\u00a0kg)\r\n3 times daily; child up to 1 year (body-weight\r\nup to 10\u00a0kg) 100\u00a0micrograms/kg (max. 1\u00a0mg) twice daily, 1\u20133 years\r\n(body-weight 10\u201314\u00a0kg) 1\u00a0mg 2\u20133 times daily, 3\u20135 years (body-weight\r\n15\u201319\u00a0kg) 2\u00a0mg 2\u20133 times daily, 5\u20139 years (body-weight 20\u201329\u00a0kg) 2.5\u00a0mg\r\n3 times daily, 9\u201315 years (body-weight 30\u00a0kg and over) 5\u00a0mg 3 times\r\ndaily", "Daily dose of metoclopramide should not normally\r\nexceed 500\u00a0micrograms/kg, particularly for children and young adults\r\n(restricted use, see above)", "For diagnostic procedures, as a single dose 5\u201310 minutes before\r\nexamination, 10\u201320\u00a0mg (10\u00a0mg in young adults 15\u201319 years); child under 3 years 1\u00a0mg, 3\u20135 years 2\u00a0mg, 5\u20139 years\r\n2.5\u00a0mg, 9\u201314 years 5\u00a0mg", "Name[Maxolon SR\u00ae (Amdipharm) ] Capsules, m/r, clear, enclosing\r\nwhite granules, metoclopramide hydrochloride 15\u00a0mg,\r\nnet price 56-cap pack = \u00a37.01. \r\n    Label:\r\n    25Dose\u00a0patients over 20 years, 1 capsule twice daily"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}, {"indications": "Indications\u00a0adults, nausea and vomiting, particularly\r\nin gastro-intestinal disorders (section 1.2) and treatment\r\nwith cytotoxics or radiotherapy; migraine (section 4.7.4.1)Patients under 20 years\u00a0Use restricted to severe\r\nintractable vomiting of known cause, vomiting of radiotherapy and\r\ncytotoxics, aid to gastro-intestinal intubation, premedication; dose\r\nshould be determined on the basis of body-weight", "name": "METOCLOPRAMIDE HYDROCHLORIDE High-dose (with cytotoxic chemotherapy only)", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.6 Drugs used in nausea and vertigo", "Domperidone and metoclopramide", "METOCLOPRAMIDE HYDROCHLORIDE", "High-dose (with cytotoxic chemotherapy only)"], "cautions": "Cautions\u00a0elderly, young\r\nadults (15\u201319 years old), and children; atopic allergy (including asthma); cardiac conduction disturbances (and concomitant\r\nuse of other drugs affecting cardiac conduction);  may mask underlying disorders such as cerebral irritation; acute porphyria (section 9.8.2); epilepsy; interactions: Appendix 1 (metoclopramide)", "side-effects": "Side-effects\u00a0extrapyramidal effects (especially in children\r\nand young adults (15\u201319 years old)\u2014see above),\r\nhyperprolactinaemia, occasionally tardive dyskinesia on prolonged\r\nadministration; also reported, dyspnoea, anxiety, confusion, drowsiness,\r\ndizziness, tremor, restlessness, diarrhoea, depression, neuroleptic\r\nmalignant syndrome, visual disturbances, rashes, pruritus, oedema;\r\ncardiac conduction abnormalities reported following intravenous administration; rarely methaemoglobinaemia (more severe in G6PD deficiency)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3435.htm", "doses": ["By mouth or by intramuscular injection or by\r\nintravenous injection over 1\u20132 minutes, nausea and vomiting,\r\n10\u00a0mg (5\u00a0mg in young adults 15\u201319 years, body-weight under 60\u00a0kg)\r\n3 times daily; child up to 1 year (body-weight\r\nup to 10\u00a0kg) 100\u00a0micrograms/kg (max. 1\u00a0mg) twice daily, 1\u20133 years\r\n(body-weight 10\u201314\u00a0kg) 1\u00a0mg 2\u20133 times daily, 3\u20135 years (body-weight\r\n15\u201319\u00a0kg) 2\u00a0mg 2\u20133 times daily, 5\u20139 years (body-weight 20\u201329\u00a0kg) 2.5\u00a0mg\r\n3 times daily, 9\u201315 years (body-weight 30\u00a0kg and over) 5\u00a0mg 3 times\r\ndaily", "Daily dose of metoclopramide should not normally\r\nexceed 500\u00a0micrograms/kg, particularly for children and young adults\r\n(restricted use, see above)", "For diagnostic procedures, as a single dose 5\u201310 minutes before\r\nexamination, 10\u201320\u00a0mg (10\u00a0mg in young adults 15\u201319 years); child under 3 years 1\u00a0mg, 3\u20135 years 2\u00a0mg, 5\u20139 years\r\n2.5\u00a0mg, 9\u201314 years 5\u00a0mg", "Name[Maxolon High Dose\u00ae (Amdipharm) ] Injection, metoclopramide\r\nhydrochloride 5\u00a0mg/mL, net price 20-mL amp = \u00a32.67.For dilution and use as an intravenous infusion\r\nin nausea and vomiting associated with cytotoxic chemotherapy onlyDose\u00a0by continuous intravenous infusion (preferred\r\nmethod), initially (before starting chemotherapy), 2\u20134\u00a0mg/kg over\r\n15\u201320 minutes, then 3\u20135\u00a0mg/kg over 8\u201312 hours; max. in 24 hours, 10\u00a0mg/kgBy intermittent intravenous infusion, initially\r\n(before starting chemotherapy), up to 2\u00a0mg/kg over at least 15 minutes\r\nthen up to 2\u00a0mg/kg over at least 15 minutes every 2 hours; max. in\r\n24 hours, 10\u00a0mg/kg"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}]